Industrial conglomerate 3M Company is partnering with the Massachusetts Institute of Technology to develop a cheaper, quicker COVID-19 test.
Right now, test results can take anywhere from a few hours to a week. Quest Diagnostics, for instance, said the average turnaround time at its labs is currently seven days.
3M's new test would function more like a pregnancy strip, a rapid paper-based test that could be mass-produced and quickly distributed at the point of care.
"In terms of patient experience, what we're looking to do is create that low-cost, highly-accurate, simple-to-use test that would be accessible to a lot of people," Dr. John Banovetz, chief technology officer for 3M, told Cheddar.
The antigen-based test, which looks at proteins on the virus, would offer a "preliminary view" of a patient's coronavirus status — though ideally, patients would follow up with a doctor, he added.
"Our goal would be a point-of-care test, so maybe it's taken in a doctor's office. Maybe you pick it up at the pharmacy," Banovetz said.
The goal is to start producing tests by the end of summer or early fall. Once manufacturing is rolling, 3M could produce millions of tests per day, according to the company.
As cases surge across the country and many anticipate a second wave in states where the infection rate has dropped off, calls for more testing are growing.
More than 41 million tests have been reported to the CDC, with a 9 percent positivity rate, but the U.S. continues to lag behind other countries by some measures.
In the meantime, the Trump administration is relying on the private sector to meet the demand for tests, putting pressure on companies such as 3M to come up with a solution.
"We're going as quick as we can right now," he said. "Our focus is trying to get that accuracy up and in a way that we know that we can mass-produce it. That's really where 3M can help contribute to this, our ability to be able to commercialize and bring to market new ideas and innovations."
Bioscience and genetic engineering company, Colossal, raised $60 million in a Series A funding round. Colossal is focused on developing new technologies and genetic tools to restore extinct species, and protect critically endangered species. One of the startup's long-term goals is to resurrect the woolly mammoth, and return it back to the arctic. Colossal also says it is developing technology that expands beyond animals, and has the potential to advance human health. Ben Lamm, co-founder and CEO of Colossal, joins Cheddar News' Closing Bell to discuss.
Residents were cleaning their homes Thursday after a 7.4-magnitude earthquake struck off the coast of Fukushima in northern Japan, smashing furniture, knocking out power and killing four people.
A New Zealand couple who believed they had dug up the world’s largest potato had their dreams turned to mash after Guinness World Records wrote to say that scientific testing had found it wasn’t, in fact, a potato after all.
Two years into the pandemic, many of us have regained a sense of normalcy. However, those in the healthcare industry are still confronting the virus every day, dealing with the physical, mental and psychological stress of the ongoing pandemic. Ben Mirtes, CFO of Ingenovis Health and Lydia Mobley, a travel nurse with Faststaff, who has spent the last two years going from hotspot to hotspot, joined Cheddar’s Opening Bell to reflect on their experiences in healthcare, and discuss why they are optimistic about a path forward.
Catching you up on what you Need to Know on March 16, 2022, with updates on Ukraine and Russia, a container ship gets stuck in the Chesapeake Bay, Disney employees stage a walkout over the "Don't Say Gay" law in Florida, and NASA completes its first spacewalk of 2022.
Food technology startup Tender Food raised $12 million in a seed round led by Chris Sacca's Lowercarbon Capital. Tender says it specializes in creating alternative meats with an authentic texture and is on a mission to make alternative meats so delicious, nutritious, and affordable, that eating meat from animals will no longer make sense. Christophe Chantre, co-founder & CEO of Tender Food, joins Cheddar News' Closing Bell to discuss.
Ryan Shearman, chief alchemist and co-founder at Aether, and Henry Elkus, founder of Helena, join Cheddar News to talk about the completion of an $18 million Series A funding round led by Helena.
As the Russia-Ukraine conflict continues to grow, so do concerns over the impact it could have on the international space community, and more specifically, the International Space Station. Those concerns come after Dmitry Rogozin, the director of Russia's state space agency, posted several tweets over the last few weeks in which he threatened to 'destroy Russia's cooperation on the ISS.' Olympia LePoint, rocket scientist and author of 'Answers Unleashed II: The Science of Attracting What You Want,' joined Cheddar News' Closing Bell to discuss.
